NEXSTAT (TM) TOPICAL HEMOSTAT POWDER; NEXFOAM (R) TOPICAL SPONGE— 510(k) K102459

Name: FDA 510(k) clearance K102459
Creator: U.S. Food and Drug Administration
Published: 2010-12-03

Substantially Equivalent

Hemostasis, LLC

FDA 510(k) clearance K102459 for NEXSTAT (TM) TOPICAL HEMOSTAT POWDER; NEXFOAM (R) TOPICAL SPONGE, Substantially Equivalent on 2010-12-03. Applicant: Hemostasis, LLC. Device class: Unclassified.

Clearance details

Applicant: Hemostasis, LLC
Product code: Code QSY
Device class: Unclassified
Advisory panel: Unknown
Date received: 2010-08-27
Decision date: 2010-12-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: St. Paul, MN, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code QSY

view all

K253017 — BloodSTOP iX Trauma Matrix (TM-iX-20)2026-04-30
K251700 — Ganymede 2cm diameter (FG100300) +14 more2026-02-26
K250319 — MFUSE (MS001)2025-12-15
K253609 — TRAUMAGEL® 2.0 Hemostatic Gel2025-12-12
K240713 — TRAUMAGEL®2024-08-14

More clearances from Hemostasis, LLC

view all

K234131 — Resolv Endoscopic Hemostat System2024-07-26
K220326 — PosiSep X BAM Hemostat Dressing/Intranasal Splint2022-11-14
K210411 — PosiSep EAR Fragmentable Ear Dressing2022-05-05
K142348 — OsteoSeal Bone Hemostat2015-01-23
K122494 — POSISEP AND POSISEP X HEMOSTAT DRESSING/INTRANASAL SPLINT2013-03-27

Adverse events under product code QSY

product code QSY

Death: 5
Other: 1
Total: 6

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.